Source 1primary paper2004Plant and Cell Physiology
Toolkit/PhyB/PIF
PhyB/PIF
Also known as: genetically encoded PhyB-PIF LID system, phyB, PhyB, phyB mutants, PhyB-PIF, PhyB/PIF, PHYB/PIF, PHYB/PIF6 system, PhyB-PIF LID system, phytochrome B / phytochrome-interacting factor, phytochrome B system, PIF, PIFs
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
PhyB/PIF is a genetically encoded red/far-red light-inducible dimerization system built from phytochrome B and phytochrome-interacting factor. It enables reversible light-controlled protein association and dissociation on the second time scale and has been applied to gene regulation, protein transport, and subcellular recruitment.
Usefulness & Problems
Why this is useful
This system provides optical control over protein interactions using red and far-red light, a wavelength pair specifically noted for PhyB/PIF among available light-inducible dimerization systems. Reported applications include regulation of gene expression, transport of proteins into organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
Source:
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Source:
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Source:
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Source:
has a unique property of controlling both association and dissociation by light on the second time scale
Problem solved
PhyB/PIF addresses the need for reversible, temporally controlled manipulation of intracellular protein association states. The cited literature and extraction notes indicate that it is used to control signaling-related interactions, localization, and gene regulation with light.
Source:
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Source:
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Source:
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Source:
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
Problem links
The gap highlights a need for combinatorial approaches that modulate multiple mechanisms and measure system-level effects. PhyB/PIF offers a concrete, genetically encoded way to perturb intracellular signaling and localization with temporal control, which could help causal dissection in model systems.
Workflow Fit
Likely fit
- •standard-construct-loop: useful when chromophore biosynthesis, localization, and signaling-output geometry need coordinated testing
- •fast-no-cloning-screen: useful only when an enablement cassette is already in hand and the goal is narrow feasibility testing
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Mechanisms
HeterodimerizationHeterodimerizationlight-inducible heterodimerizationreversible light-controlled dissociationTechniques
No technique tags yet.
Target processes
localizationsignalingInput: Light
Output: Signaling
Implementation Constraints
cofactor dependency: cofactor requirement unknowncofactor dependency: requires exogenous cofactorencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenimplementation constraint: payload burdenimplementation constraint: spectral hardware requirementmechanism class: light-dependent bindingoperating role: actuatoroperating role: regulatoroperating role: sensoroptogenetic: Truephotoreceptor family: phytochromereversible: Truesubcellular localization control: Trueswitch architecture: multi componentswitch architecture: recruitmentvertebrate embryo use: True
The system requires expression of PhyB and PIF components together with a bilin chromophore, specifically phytochromobilin or phycocyanobilin according to the extraction notes. In the cited context, chromophore support in mammalian cells was provided through synPCB and inducible vector delivery.
The supplied evidence indicates that the system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin. The extraction notes also state that chromophore availability remains a barrier in non-plant and non-cyanobacterial cells unless additional biosynthetic support is provided.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Observations
successMammalian Cell Lineapplication demo
Inferred from claim c3 during normalization. The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system. Derived from claim c3. Quoted text: successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
Source:
Supporting Sources
Source 2review2021Biotechnology and Bioengineering
Source 3primary paper2004The Plant Cell
Source 4primary paper2017Proceedings of the National Academy of Sciences
Source 5primary paper2020
Source 6review2017Journal of Experimental Neuroscience
Source 7review2014Biotechnology Journal
Source 8review2016Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Source 9primary paper2016eLife
Source 10primary paper2012The Plant Journal
Source 11primary paper2007The Plant Journal
Source 12primary paper2016Developmental Cell
Source 13review2021Chemical Reviews
Ranked Claims
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Clinical application of optogenetic gene regulation is limited by unanswered questions including exogenous chromophore use and gentle but effective transfection methods for in vivo applications.
Among the many unanswered questions concerning the application of optogenetics, we discuss items such as the use of exogenous chromophores and their effects on the biology of the cells and methods for a gentle, but effective gene transfection method for optogenetic tools for in vivo applications.
Phytochromes have an intrinsic advantage over other photoreceptor classes because their bidirectional dual-wavelength control enables instant ON and OFF regulation.
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Phytochromes have an intrinsic advantage over other photoreceptor classes because their bidirectional dual-wavelength control enables instant ON and OFF regulation.
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Phytochromes have an intrinsic advantage over other photoreceptor classes because their bidirectional dual-wavelength control enables instant ON and OFF regulation.
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Phytochromes have an intrinsic advantage over other photoreceptor classes because their bidirectional dual-wavelength control enables instant ON and OFF regulation.
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Phytochromes have an intrinsic advantage over other photoreceptor classes because their bidirectional dual-wavelength control enables instant ON and OFF regulation.
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Phytochrome-based optogenetic tools are implemented across bacteria, yeast, plants, and animals to control diverse biological activities.
Phytochrome-based optogenetic tools are currently implemented in bacteria, yeast, plants, and animals to achieve light control of a wide range of biological activities.
Phytochrome-based optogenetic tools are implemented across bacteria, yeast, plants, and animals to control diverse biological activities.
Phytochrome-based optogenetic tools are currently implemented in bacteria, yeast, plants, and animals to achieve light control of a wide range of biological activities.
Phytochrome-based optogenetic tools are implemented across bacteria, yeast, plants, and animals to control diverse biological activities.
Phytochrome-based optogenetic tools are currently implemented in bacteria, yeast, plants, and animals to achieve light control of a wide range of biological activities.
Phytochrome-based optogenetic tools are implemented across bacteria, yeast, plants, and animals to control diverse biological activities.
Phytochrome-based optogenetic tools are currently implemented in bacteria, yeast, plants, and animals to achieve light control of a wide range of biological activities.
Phytochrome-based optogenetic tools are implemented across bacteria, yeast, plants, and animals to control diverse biological activities.
Phytochrome-based optogenetic tools are currently implemented in bacteria, yeast, plants, and animals to achieve light control of a wide range of biological activities.
The review describes engineering of phytochromes to improve them as photoswitches and surveys their use in optogenetic applications.
Based on this knowledge, we then describe the engineering of phytochromes to further improve these chromoproteins as photoswitches and review their employment in an ever-growing number of different optogenetic applications.
The review describes engineering of phytochromes to improve them as photoswitches and surveys their use in optogenetic applications.
Based on this knowledge, we then describe the engineering of phytochromes to further improve these chromoproteins as photoswitches and review their employment in an ever-growing number of different optogenetic applications.
The review describes engineering of phytochromes to improve them as photoswitches and surveys their use in optogenetic applications.
Based on this knowledge, we then describe the engineering of phytochromes to further improve these chromoproteins as photoswitches and review their employment in an ever-growing number of different optogenetic applications.
The review describes engineering of phytochromes to improve them as photoswitches and surveys their use in optogenetic applications.
Based on this knowledge, we then describe the engineering of phytochromes to further improve these chromoproteins as photoswitches and review their employment in an ever-growing number of different optogenetic applications.
The review describes engineering of phytochromes to improve them as photoswitches and surveys their use in optogenetic applications.
Based on this knowledge, we then describe the engineering of phytochromes to further improve these chromoproteins as photoswitches and review their employment in an ever-growing number of different optogenetic applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
The long-wavelength absorption and fluorescence of phytochromes within the transparent window make them attractive for applications requiring deep tissue penetration or combination with blue and UV light-sensing photoreceptors.
In particular, the long wavelength range of absorption and fluorescence within the "transparent window" makes phytochromes attractive for complex applications requiring deep tissue penetration or dual-wavelength control in combination with blue and UV light-sensing photoreceptors.
The long-wavelength absorption and fluorescence of phytochromes within the transparent window make them attractive for applications requiring deep tissue penetration or combination with blue and UV light-sensing photoreceptors.
In particular, the long wavelength range of absorption and fluorescence within the "transparent window" makes phytochromes attractive for complex applications requiring deep tissue penetration or dual-wavelength control in combination with blue and UV light-sensing photoreceptors.
The long-wavelength absorption and fluorescence of phytochromes within the transparent window make them attractive for applications requiring deep tissue penetration or combination with blue and UV light-sensing photoreceptors.
In particular, the long wavelength range of absorption and fluorescence within the "transparent window" makes phytochromes attractive for complex applications requiring deep tissue penetration or dual-wavelength control in combination with blue and UV light-sensing photoreceptors.
The long-wavelength absorption and fluorescence of phytochromes within the transparent window make them attractive for applications requiring deep tissue penetration or combination with blue and UV light-sensing photoreceptors.
In particular, the long wavelength range of absorption and fluorescence within the "transparent window" makes phytochromes attractive for complex applications requiring deep tissue penetration or dual-wavelength control in combination with blue and UV light-sensing photoreceptors.
The long-wavelength absorption and fluorescence of phytochromes within the transparent window make them attractive for applications requiring deep tissue penetration or combination with blue and UV light-sensing photoreceptors.
In particular, the long wavelength range of absorption and fluorescence within the "transparent window" makes phytochromes attractive for complex applications requiring deep tissue penetration or dual-wavelength control in combination with blue and UV light-sensing photoreceptors.
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
The PhyB-PIF light-inducible dimerization system controls both association and dissociation by light on the second time scale.
has a unique property of controlling both association and dissociation by light on the second time scale
response timescale second time scale
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.
resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Depletion of biliverdin reductase A increases intracellular phycocyanobilin concentration.
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
An expression vector coexpressing HO1, PcyA, ferredoxin, and ferredoxin-NADP+ reductase enables efficient synthesis of phycocyanobilin in mammalian cell mitochondria.
Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells.
The paper demonstrates in vivo manipulation of the polarity protein Pard3 using the PHYB/PIF optogenetic localization system.
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
PCB is required for use of the PHYB/PIF system in vertebrate embryos because vertebrate cells do not naturally produce the phytochrome chromophore.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
Manipulating PCH1 alters PIF4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PHYTOCHROME INTERACTING FACTOR 4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PIF4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PHYTOCHROME INTERACTING FACTOR 4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PIF4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PHYTOCHROME INTERACTING FACTOR 4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PIF4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PHYTOCHROME INTERACTING FACTOR 4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PIF4 levels and regulates light-responsive gene expression.
Manipulating PCH1 alters PHYTOCHROME INTERACTING FACTOR 4 levels and regulates light-responsive gene expression.
The study describes optimization of the Arabidopsis PHYB/PIF6 red/far-red optogenetic heterodimerization system for live zebrafish embryos to enable rapid, reversible subcellular protein recruitment.
Photoreceptor-based optogenetic tools in this review rely on light-dependent reversible binding to specific interaction partners.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
PIF4 and PIF5 regulate elongation growth by directly controlling expression of genes encoding auxin biosynthesis and auxin signaling components.
our study suggests that PIF4 and PIF5 regulate elongation growth by controlling directly the expression of genes that code for auxin biosynthesis and auxin signaling components
PIF4 and PIF5 regulate elongation growth by directly controlling expression of genes encoding auxin biosynthesis and auxin signaling components.
our study suggests that PIF4 and PIF5 regulate elongation growth by controlling directly the expression of genes that code for auxin biosynthesis and auxin signaling components
PIF4 and PIF5 regulate elongation growth by directly controlling expression of genes encoding auxin biosynthesis and auxin signaling components.
our study suggests that PIF4 and PIF5 regulate elongation growth by controlling directly the expression of genes that code for auxin biosynthesis and auxin signaling components
PIF4 and PIF5 regulate elongation growth by directly controlling expression of genes encoding auxin biosynthesis and auxin signaling components.
our study suggests that PIF4 and PIF5 regulate elongation growth by controlling directly the expression of genes that code for auxin biosynthesis and auxin signaling components
PIF4 and PIF5 regulate elongation growth by directly controlling expression of genes encoding auxin biosynthesis and auxin signaling components.
our study suggests that PIF4 and PIF5 regulate elongation growth by controlling directly the expression of genes that code for auxin biosynthesis and auxin signaling components
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Shade avoidance in dense vegetation is triggered at least partially by reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Our data suggest that, in dense vegetation, which is rich in far-red light, shade avoidance is triggered, at least partially, as a consequence of reduced phytochrome-mediated degradation of transcription factors such as PIF4 and PIF5.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
Degradation of PIF4 and PIF5 is preceded by phosphorylation, requires the APB domain, and is sensitive to proteasome inhibitors, suggesting degradation upon interaction with light-activated phyB.
Degradation of these transcription factors is preceded by phosphorylation, requires the APB domain and is sensitive to inhibitors of the proteasome, suggesting that PIF4 and PIF5 are degraded upon interaction with light-activated phyB.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including early flowering, are similar to those of phyB mutants.
The developmental morphologies of PIL6-ox, including the phenotype of early flowering, were also similar to those of phyB mutants.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with phytochrome species is transient.
Rapid light-induced degradation of PIF3 indicates that interaction of PIF3 with these phytochrome species is transient.
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
Light-induced PIF3 degradation is controlled by the concerted action of phyA, phyB, and phyD photoreceptors.
This process is controlled by the concerted action of the R/FR absorbing phyA, phyB, and phyD photoreceptors
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
PIL6-ox plants are hyposensitive to red light.
transgenic plants overexpressing PIL6 (PIL6-ox) are hyposensitive to red light under the same conditions
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The pil6-1 loss-of-function mutant is hypersensitive to red light in seedling de-etiolation.
the loss-of-function mutant (pil6-1) showed a remarkable phenotype in that it is hypersensitive to red light in seedling de-etiolation
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hypersensitive phenotype of pil6-1 is similar to that of transgenic lines overexpressing TOC1/APRR1.
This phenotype was similar to that observed for transgenic lines overexpressing TOC1 (or APRR1).
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
The red-light hyposensitive phenotype of PIL6-ox is very similar to that of phyB mutants.
This phenotype was very similar to that observed for phyB mutants.
Approval Evidence
13 sources26 linked approval claimsfirst-pass slugs phyb, phyb-pif, phyb-pif-light-controlled-interaction-system, phyb-pif-light-inducible-dimerization-system, phyb-pif-optogenetic-system, phyb-pif-system, phytochrome-b
Well-known systems for gene regulation, such as the LOV-, CRY2/CIB-, PhyB/PIF-systems
Source:
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs)
Source:
One of the red/far-red responsive LID system, phytochrome B (PhyB)-phytochrome interacting factor (PIF)
Source:
Among them, the phytochrome B (PhyB)-phytochrome-interacting factor (PIF) system is the only available LID system controlled by red and far-red lights.
Source:
Explicitly supported in the supplied web research summary as a canonical light-induced dimerization pair aligned with the review scope.
Source:
The supplied web research summary identifies PhyB/PIF as a major photoreceptor-based system explicitly aligned with the review's scope in mammalian signaling optogenetics.
Source:
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner, and co-localizes with phyB into photobodies.
Source:
web_research_summary states that the paper describes optimization of the Arabidopsis PHYB/PIF6 red/far-red optogenetic heterodimerization system for live zebrafish embryos, enabling rapid, reversible, subcellular protein recruitment.
Source:
These tools are based on photoreceptors such as phytochrome B (PhyB) ... that reversibly bind to specific interaction partners in a light-dependent manner.
Source:
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Source:
light-activated phytochrome B (phyB)
Source:
This phenotype was very similar to that observed for phyB mutants.
Source:
application examplessupports
Applications of phytochrome-based tools include regulation of gene expression, protein transport into cell organelles, and recruitment of tagged proteins to membranes and other cellular compartments.
These cover the regulation of gene expression, protein transport into cell organelles, and the recruitment of phytochrome- or PIF-tagged proteins to membranes and other cellular compartments.
Source:
application potentialsupports
Optogenetic gene regulation may enable spatially and temporally regulated gene and protein expression for cell therapeutic approaches.
Here optogenetic gene regulation might offer an excellent method for spatially and timely regulated gene and protein expression in cell therapeutic approaches.
Source:
application prevalencesupports
Most phytochrome optogenetic applications described in the review rely on the light-controlled interaction between PhyB and PIFs or on C-terminal light-regulated enzymatic domains from bacterial and algal phytochromes.
Most applications rely on the light-controlled complex formation between the plant photoreceptor PhyB and phytochrome-interacting factors (PIFs) or C-terminal light-regulated domains with enzymatic functions present in many bacterial and algal phytochromes.
Source:
scope statementsupports
This review focuses on optogenetic control of gene expression in mammalian cells as models relevant to clinical applications.
This review will be confined to the optogenetic control of gene expression in mammalian cells as suitable models for clinical applications.
Source:
inducible expression capabilitysupports
Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.
we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Source:
requirementsupports
The PhyB-PIF red/far-red responsive light-inducible dimerization system requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin.
PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB)
Source:
system establishmentsupports
The authors successfully established a stable cell line containing a genetically encoded PhyB-PIF light-inducible dimerization system.
successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system
Source:
applicationsupports
The PCB synthesis system together with the PhyB-PIF system enables optogenetic regulation of intracellular signaling without external chromophore supply.
The PCB synthesis and PhyB-PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores.
Source:
practical methodsupports
This work provides a practical method for a fully genetically encoded PhyB-PIF system.
Thus, we have provided a practical method for developing a fully genetically encoded PhyB-PIF system, which paves the way for its application to a living animal.
Source:
application demosupports
The paper demonstrates in vivo manipulation of the polarity protein Pard3 using the PHYB/PIF optogenetic localization system.
Source:
binding interactionsupports
PCH1 binds phytochrome B in a red light-dependent manner.
PCH1 peaks at dusk, binds phytochrome B (phyB) in a red light-dependent manner
Source:
cofactor requirementsupports
PCB is required for use of the PHYB/PIF system in vertebrate embryos because vertebrate cells do not naturally produce the phytochrome chromophore.
Source:
colocalizationsupports
PCH1 co-localizes with phytochrome B into photobodies.
and co-localizes with phyB into photobodies.
Source:
integrative functionsupports
PCH1 regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB signaling.
Thus, PCH1 is a new factor that regulates photoperiod-responsive growth by integrating the clock with light perception pathways through modulating daily phyB-signaling.
Source:
mechanistic rolesupports
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies and maintain an active phyB pool after light exposure.
PCH1 is necessary and sufficient to promote the biogenesis of large photobodies to maintain an active phyB pool after light exposure
Source:
tool capabilitysupports
The study describes optimization of the Arabidopsis PHYB/PIF6 red/far-red optogenetic heterodimerization system for live zebrafish embryos to enable rapid, reversible subcellular protein recruitment.
Source:
mechanism summarysupports
Photoreceptor-based optogenetic tools in this review rely on light-dependent reversible binding to specific interaction partners.
Source:
biological rolesupports
Phytochrome B is the major light sensor mediating the adaptive shade-avoidance response.
The phytochrome B (phyB) photoreceptor is the major light sensor to mediate this adaptive response.
Source:
regulatory relationshipsupports
Phytochrome B directly controls the protein abundance of PIF4 and PIF5 as part of shade-avoidance syndrome control.
Control of the SAS occurs in part with phyB, which controls protein abundance of phytochrome-interacting factors 4 and 5 (PIF4 and PIF5) directly.
Source:
genetic interactionsupports
The constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Consistent with this idea, the constitutive shade-avoidance phenotype of phyB mutants partially reverts in the absence of PIF4 and PIF5.
Source:
Comparisons
Source-backed strengths
The available evidence states that PhyB/PIF is controlled by red and far-red light and can drive both association and dissociation on the second time scale. It has been used across multiple application classes, including gene expression control, protein transport, and compartment-specific recruitment.
Source:
This compilation illustrates the intrinsic advantages of phytochromes compared to other photoreceptor classes, e.g., their bidirectional dual-wavelength control enabling instant ON and OFF regulation.
Source:
these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
Source:
An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB.
Compared with fusion proteins with large N-terminal anchors
PhyB/PIF and fusion proteins with large N-terminal anchors address a similar problem space because they share localization, signaling.
Shared frame: same top-level item type; shared target processes: localization, signaling; shared mechanisms: heterodimerization; same primary input modality: light
Strengths here: appears more independently replicated.
Relative tradeoffs: may avoid an exogenous cofactor requirement.
Compared with iLID/SspB
PhyB/PIF and iLID/SspB address a similar problem space because they share localization, signaling.
Shared frame: same top-level item type; shared target processes: localization, signaling; shared mechanisms: heterodimerization; same primary input modality: light
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice; may avoid an exogenous cofactor requirement.
Compared with LOVpep/ePDZb
PhyB/PIF and LOVpep/ePDZb address a similar problem space because they share localization, signaling.
Shared frame: same top-level item type; shared target processes: localization, signaling; shared mechanisms: heterodimerization; same primary input modality: light
Strengths here: appears more independently replicated.
Relative tradeoffs: looks easier to implement in practice; may avoid an exogenous cofactor requirement.
Ranked Citations
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
Extracted from this source document.
- 7.
- 8.
Extracted from this source document.
- 9.
- 10.
- 11.
- 12.
- 13.